ATRC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Atricure Inc

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator ® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip ® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.
CEO
Employees
750
Headquarters

News

AtriCure (ATRC) Presents At Oppenheimer 33rd Annual Health Conference - Slideshow
Mar 21, 2023 15:06pm

The following slide deck was published by AtriCure, Inc.


Source:Seeking Alpha
AtriCure, Inc. (ATRC) Q4 2022 Earnings Call Transcript
Feb 22, 2023 03:47am

AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin Group, Investor RelationsMichael Carrel -…


Source:Seeking Alpha
AtriCure: Q4 Earnings Snapshot
Feb 21, 2023 21:13pm

MASON, Ohio (AP) — MASON, Ohio (AP) — AtriCure Inc. (ATRC) on Tuesday reported a loss of $4.2 million in…


Source:WTOP
AtriCure GAAP EPS of -$0.09 beats by $0.09, revenue of $88M beats by $0.1M
Feb 21, 2023 21:04pm

AtriCure press release (ATRC): Q4 GAAP EPS of -$0.09 beats by $0.09.Revenue of $88M (+20.2% Y/Y) beats by $0.1M.Adjusted EBITDA was positive for the fourth quarter 2022 at $6.0…


Source:Seeking Alpha
AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results
Feb 21, 2023 21:00pm

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2022 and full year 2022 financial results. “We delivered another outstanding year of growth in 2022, as we expanded adoption across our broad portfolio of solutions. I


Source:Wallstreet:Online
Earnings Outlook For AtriCure
Feb 20, 2023 15:00pm

AtriCure (NASDAQ: ATRC ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here''s what investors need to know before the announcement. Analysts estimate that AtriCure will report an earnings per share (EPS) of $-0.18. AtriCure bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com


Source:Benzinga
AtriCure, Inc.: AtriCure Announces the First Patient Treated in the LeAAPS Clinical Trial
Jan 31, 2023 13:06pm

Trial will evaluate the safety and effectiveness of the AtriCure AtriClip Left Atrial Appendage Exclusion System for stroke prevention in cardiac surgery patients AtriCure, Inc. (Nasdaq: ATRC), a …


Source:Finanz Nachrichten
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
Jan 31, 2023 13:00pm

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was treated in the Left Atrial Appendage Exclusion for Stroke Prevention (LeAAPS™) clinical trial (NCT 05478304). The patient was treated by U.S. co-principal investigator Dr. Marc Gerdisch at Franciscan St. Francis Heart Center in Ind


Source:Business Wire
AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference
Jan 24, 2023 13:00pm

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, February 21, 2023, to discuss its fourth quarter and full year 2022 financi


Source:Business Wire